Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
Testicular germ cell tumors share a marked sensitivity to cisplatin, contributing to their overall good prognosis. However, a subset of patients develop resistance to platinum-based treatments, by still-elusive mechanisms, experiencing poor quality of life due to multiple (often ineffective) interve...
Main Authors: | João Lobo, Carmen Jerónimo, Rui Henrique |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1601 |
Similar Items
-
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
by: João Lobo, et al.
Published: (2020-10-01) -
Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors
by: André van Helvoort Lengert, et al.
Published: (2022-08-01) -
Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours
by: Jan Roška, et al.
Published: (2023-01-01) -
Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors
by: Violeta Bakardjieva-Mihaylova, et al.
Published: (2019-09-01) -
Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours
by: Zeeshan Fazal, et al.
Published: (2021-10-01)